- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
October 8th, 2007
A swaggering Texas investor with a famous name wants Big Pharma to pick up the tab for the International Space Station when NASA eases off.
Thomas Pickens III thinks the pharmaceutical industry and the space station need each other.
Drug discovery is an arduous and extremely expensive project. But in space, molecules do miraculous things. Disease-causing proteins crystallize so well -- growing larger and clearer -- that finding a drug to stop the protein's damaging activities could happen months, if not years, faster.
Scientists have known for decades that some science works better in space -- but it hasn't been easy to get experiments up there. Now, with NASA planning to reduce its $2.6 billion annual investment beginning in 2015, the agency is throwing the space station open for private enterprise. And the Texas financial scion and multimillionaire is ready to transform space science with an injection of capitalism.
|Related News Press|
Nanoparticles simplify DNA identification and quantification November 27th, 2015
Scientists 'see' detailed make-up of deadly toxin for the first time: Exciting advance provides hope for developing novel potential method of treating pneumococcal diseases such as bacterial pneumonia, meningitis and septicaemia November 25th, 2015
Electric fields remove nanoparticles from blood with ease November 24th, 2015
Graphene microphone outperforms traditional nickel and offers ultrasonic reach November 29th, 2015
Coming to a monitor near you: A defect-free, molecule-thick film November 29th, 2015
Increasing Impact Resistance of Polypropylene by Nanoparticles November 20th, 2015
Production of Special Coating to Increase Efficiency of Solar Cells in Iran October 26th, 2015